The impact of cyclooxygenase inhibitor use on urinary prostaglandin metabolites in preterm infants
Background: There is limited evidence on the association between the clinical course of patent ductus arteriosus (PDA) and prostaglandin (PG) metabolites. This study aimed to determine the influence of PDA treatment on urinary PG metabolite excretion in very-low-birth-weight (VLBW) infants. Methods:...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2024-03-01
|
| Ráidu: | Pediatrics and Neonatology |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S1875957223001328 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|